BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND NFATC2, ENSG00000101096, 4773, Q13469, NFATP, NFAT1, KIAA0611
26 results:

  • 1. Human complete nfat1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy.
    Sharma M; Fu MP; Lu HY; Sharma AA; Modi BP; Michalski C; Lin S; Dalmann J; Salman A; Del Bel KL; Waqas M; Terry J; Setiadi A; Lavoie PM; Wasserman WW; Mwenifumbo J; Kobor MS; Lee AF; Kuchenbauer F; Lehman A; Cheng S; Cooper A; Patel MS; Turvey SE
    Blood; 2022 Oct; 140(17):1858-1874. PubMed ID: 35789258
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
    Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
    PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3.
    Liu S; Gao C; Wu Y; Lin W; Li J; Xue T; Wang L; Zheng H; Zhang R
    Pharmacogenomics; 2021 Nov; 22(17):1135-1142. PubMed ID: 34747637
    [No Abstract]    [Full Text] [Related]  

  • 4. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/nfatc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identifying the Cellular Interactome of Epstein-Barr Virus Lytic Regulator Zta Reveals Cellular Targets Contributing to Viral Replication.
    Zhou Y; Heesom K; Osborn K; AlMohammed R; Sweet SM; Sinclair AJ
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694936
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. nfat1 transcription factor regulates cell cycle progression and cyclin E expression in B lymphocytes.
    Teixeira LK; Carrossini N; Sécca C; Kroll JE; DaCunha DC; Faget DV; Carvalho LD; de Souza SJ; Viola JP
    Cell Cycle; 2016 Sep; 15(17):2346-59. PubMed ID: 27399331
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NFAT2 Isoforms Differentially Regulate Gene Expression, Cell Death, and Transformation through Alternative N-Terminal Domains.
    Lucena PI; Faget DV; Pachulec E; Robaina MC; Klumb CE; Robbs BK; Viola JP
    Mol Cell Biol; 2016 Jan; 36(1):119-31. PubMed ID: 26483414
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genome-wide analysis links nfatc2 with asparaginase hypersensitivity.
    Fernandez CA; Smith C; Yang W; Mullighan CG; Qu C; Larsen E; Bowman WP; Liu C; Ramsey LB; Chang T; Karol SE; Loh ML; Raetz EA; Winick NJ; Hunger SP; Carroll WL; Jeha S; Pui CH; Evans WE; Devidas M; Relling MV
    Blood; 2015 Jul; 126(1):69-75. PubMed ID: 25987655
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Etiology and outcomes for patients infected with HIV in intensive care units in a tertiary care hospital in China.
    Xiao J; Zhang W; Huang Y; Tian Y; Su W; Li Y; Zhang W; Han N; Yang D; Zhao H
    J Med Virol; 2015 Mar; 87(3):366-74. PubMed ID: 25154318
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CD30-positive peripheral T-cell lymphomas share molecular and phenotypic features.
    Bisig B; de Reyniès A; Bonnet C; Sujobert P; Rickman DS; Marafioti T; Delsol G; Lamant L; Gaulard P; de Leval L
    Haematologica; 2013 Aug; 98(8):1250-8. PubMed ID: 23716562
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Wnt5a is secreted by follicular dendritic cells to protect germinal center B cells via Wnt/Ca2+/NFAT/NF-κB-B cell lymphoma 6 signaling.
    Kim J; Kim DW; Chang W; Choe J; Kim J; Park CS; Song K; Lee I
    J Immunol; 2012 Jan; 188(1):182-9. PubMed ID: 22124122
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study.
    Federico M; Guglielmi C; Luminari S; Mammi C; Marcheselli L; Gianelli U; Maiorana A; Merli F; Bellei M; Pozzi S; Stelitano C; Lazzaro A; Gobbi PG; Baldini L; Bergantini S; Fregoni V; Brugiatelli M
    Haematologica; 2007 Nov; 92(11):1482-8. PubMed ID: 18024396
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Defective CD3gamma gene transcription is associated with nfatc2 overexpression in the lymphocytic variant of hypereosinophilic syndrome.
    Willard-Gallo KE; Badran BM; Ravoet M; Zerghe A; Burny A; Martiat P; Goldman M; Roufosse F; Sibille C
    Exp Hematol; 2005 Oct; 33(10):1147-59. PubMed ID: 16219537
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Monoclonal antibodies for the treatment of hematologic malignancies: clinical trials in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S90-6. PubMed ID: 12819934
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor.
    Kondo E; Harashima A; Takabatake T; Takahashi H; Matsuo Y; Yoshino T; Orita K; Akagi T
    Eur J Immunol; 2003 Jan; 33(1):1-11. PubMed ID: 12594826
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical trials of a mouse-human chimeric anti-CD20 monoclonal antibody (rituximab) for B cell non-Hodgkin's lymphoma in Japan.
    Tobinai K
    Cancer Chemother Pharmacol; 2001 Aug; 48 Suppl 1():S85-90. PubMed ID: 11587374
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines.
    Tsatsanis C; Patriotis C; Bear SE; Tsichlis PN
    Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3827-32. PubMed ID: 9520452
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. HMG I(Y) interferes with the DNA binding of NF-AT factors and the induction of the interleukin 4 promoter in T cells.
    Klein-Hessling S; Schneider G; Heinfling A; Chuvpilo S; Serfling E
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15311-6. PubMed ID: 8986808
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. NF-AT-Driven interleukin-4 transcription potentiated by NIP45.
    Hodge MR; Chun HJ; Rengarajan J; Alt A; Lieberson R; Glimcher LH
    Science; 1996 Dec; 274(5294):1903-5. PubMed ID: 8943202
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.